| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 04/06/2011 | CN101307065B N-heterocyclic dicarbene metal complex connected with ether chain, method for preparing same and use |
| 04/05/2011 | CA2475434C Aromatic amino acid derivatives and medicinal compositions |
| 03/31/2011 | WO2010142616A3 Deprotection of boc-protected compounds |
| 03/31/2011 | WO2010085377A3 Hydroxamic acid derivatives |
| 03/31/2011 | US20110077273 New benzimidazole derivatives |
| 03/31/2011 | US20110077236 New carboxylic acid amides, the preparation thereof and their use as medicaments |
| 03/30/2011 | EP2301544A1 Quinoline derivatives as intermediates to mycobacterial inhibitors |
| 03/29/2011 | US7915299 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes |
| 03/29/2011 | US7915293 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases |
| 03/29/2011 | CA2610354C Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2471730C Process for preparing and purifying 1,7'-dimethyl-2'-propyl-2,5'-bi-1h-benzimidazole |
| 03/29/2011 | CA2436980C Amido ether substituted imidazoquinolines |
| 03/24/2011 | WO2010120872A3 Method of decreasing pro-adam10 secretase and/or beta secretase levels |
| 03/24/2011 | US20110071150 Indole derivatives as crac modulators |
| 03/24/2011 | US20110071130 2-aminobenzimidazoles for treating neurodegenerative diseases |
| 03/24/2011 | US20110071126 Inhibitors of beta-secretase |
| 03/23/2011 | EP2298738A1 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 03/23/2011 | CN101555231B Method for preparing triclabendazole |
| 03/22/2011 | CA2432572C Oxybenzamides derivatives as factor xa inhibitors |
| 03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
| 03/17/2011 | US20110065728 Lipoprotein lipase-activating compositions comprising benzene derivatives |
| 03/16/2011 | EP2295402A2 Antibacterial agents |
| 03/16/2011 | EP1809598B1 Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 03/15/2011 | US7906654 (S)(-)-2-(7-chloro-6-fluoro-1H-benzimidazol-1-yl)-N-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide; treatment of pain; vanilloid receptor inhibitor; Antagonists maintain analgesic properties, but avoid pungency and neurotoxicity side effects of agonists |
| 03/15/2011 | US7906543 Method of reducing imiquimod impurity formation |
| 03/15/2011 | US7906541 Process to prepare new substituted 1H-benzo[d]imidazol-2(3H)-ones, new intermediates and their use as BACE 1 inhibitors |
| 03/15/2011 | US7906512 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases |
| 03/15/2011 | US7905954 Nanosized particles of benzimidazolone pigments |
| 03/15/2011 | CA2432000C Pyrimidineamines as angiogenesis modulators |
| 03/15/2011 | CA2397366C Methanocarba cycloalkyl nucleoside analogues |
| 03/15/2011 | CA2360415C Benzimidazole vascular damaging agents |
| 03/10/2011 | WO2010117756A3 Substituted benzimidazole pharmaceutical formulations |
| 03/10/2011 | US20110059962 Transcription factor modulating compounds and methods of use thereof |
| 03/09/2011 | EP2291352A2 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway |
| 03/09/2011 | EP2291076A1 Angiotensin ii receptor antagonists |
| 03/09/2011 | EP1874770B1 Phenylacetamides suitable as protein kinase inhibitors |
| 03/09/2011 | EP1620434B1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 03/09/2011 | CN101983962A Preparation technology of telmisartan active pharmaceutical ingredient |
| 03/08/2011 | US7902246 Methods for controlling formation of imiquimod impurities for two months, four months, and six months |
| 03/08/2011 | US7902245 Methods for reducing imiquimod impurities for two months, four months, and six months |
| 03/08/2011 | US7902244 Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation (at least four months storage) |
| 03/08/2011 | US7902243 Methods for improving imiquimod availability at two months, four months and six months between refined and compendial |
| 03/08/2011 | US7902242 Method of stabilizing imiquimod |
| 03/08/2011 | CA2488202C 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 03/08/2011 | CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels |
| 03/08/2011 | CA2420899C Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/02/2011 | CN101983190A Fluorine derivatives for organic electroluminescence devices |
| 03/02/2011 | CN101193869B Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/01/2011 | US7897633 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism |
| 02/24/2011 | WO2011020288A1 Substituted hydrazide compounds and application thereof |
| 02/24/2011 | WO2010146187A3 Process for the preparation of telmisartan |
| 02/24/2011 | US20110046378 Novel Imaging Agents for Detecting Neurological Dysfunction |
| 02/24/2011 | US20110046133 Organic compounds |
| 02/24/2011 | CA2771234A1 Substituted hydrazide compounds and use thereof |
| 02/23/2011 | EP2285784A1 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
| 02/23/2011 | EP2035401B1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 02/23/2011 | EP1268096B2 Extrusion die |
| 02/23/2011 | CN101979383A Method for synthesizing hydrobenzole hydrochloride |
| 02/22/2011 | CA2444062C Novel use of 2h-benzimidazol-2-one,1,3-dihydro-1-(2{4-[3-(trifluoromethyl)phenyl]-1-piperazinyl}ethyl)- and its physiologically acceptable acid addition salts |
| 02/17/2011 | WO2011019781A1 Process for preparing 2-arylamino or heteroarylamino substituted benzimidazole compounds |
| 02/17/2011 | WO2011018994A1 Phthalocyanine compound, preparation method therefor, and coloring composition including said phthalocyanine compound |
| 02/17/2011 | WO2010124097A3 Transcription factor modulating compounds and methods of use thereof |
| 02/17/2011 | US20110040101 Alanine racemase chiral binaphthol derivative with powerful hydrogen bond donor, and optical resolution and optical transformation methods using the same |
| 02/17/2011 | US20110039905 Benzimidazole derivatives as calcium channel blockers |
| 02/17/2011 | US20110039895 Prolyl hydroxylase inhibitors |
| 02/16/2011 | EP2284152A2 Substituted tetracycline compounds |
| 02/16/2011 | CN101977909A Dexlansoprazole process and polymorphs |
| 02/16/2011 | CN101973942A Method for synthesizing 2-(1-benzimidazolyl) ethylamine |
| 02/16/2011 | CN101973829A Trifluoromethylation of trifluoromethyl aryl sulfonium salt to heterocyclic compound under metal trigger |
| 02/16/2011 | CN101205214B Benzimidazole compounds for antiphlogistic and analgesic actions |
| 02/15/2011 | US7888515 Method for the production of N,N-carbonyldiazoles |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/10/2011 | US20110034528 Elansolids, Novel Natural Metabolites of Flexibacter and Antibiotically Active Derivatives Thereof |
| 02/10/2011 | US20110034527 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 02/10/2011 | US20110034526 Benzimidazole Compounds |
| 02/10/2011 | US20110033393 Hydrazone Compounds and Their Use |
| 02/09/2011 | EP2281819A1 Benzimidazolyl or benzoxazolyl derivatives |
| 02/09/2011 | EP2280947A1 Production of 1,7´-dimethyl-2´-propyl-2,5´-bi-1h-benzimidazole |
| 02/09/2011 | EP2280706A1 Lipoprotein lipase-activating compositions comprising benzene derivates |
| 02/09/2011 | CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors |
| 02/09/2011 | CN101970409A Uv-filter compounds |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/08/2011 | US7884120 microbiocides such as 2-(2-methyl-1H-indol-3-yl)-3a,11b-dihydro-1H-phenanthro[9,10-d]imidazole; bactericides; fungicides |
| 02/08/2011 | US7883574 Methods of making nanosized particles of benzimidazolone pigments |
| 02/08/2011 | CA2586179C Sulfonyl benzimidazole derivatives |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/08/2011 | CA2442319C Carboxylic acid derivative and salt thereof |
| 02/08/2011 | CA2355717C 1,2-annelated quinoline derivatives |
| 02/03/2011 | WO2011013752A1 Pharmaceutical composition containing fused hetero-ring derivative |
| 02/02/2011 | EP2279177A1 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/02/2011 | EP2279159A2 2'-halobiphenyl-4-yl intermediates in the synthesis of angiotensin ii antagonists |
| 02/02/2011 | EP1485358B1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
| 02/02/2011 | CN101962367A Method for purifying bendamustine hydrochloride |
| 02/02/2011 | CN101962366A Diphenyl thioether linked bis-imidazoline ligand compound and preparation method thereof |
| 02/02/2011 | CN101481355B Preparation of 2-substituted benzimidazole |
| 02/01/2011 | US7880020 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 02/01/2011 | US7880016 substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, the product thus ned is hydrogenated, optionally amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand, without isolation salt is formed |
| 02/01/2011 | US7879995 organic electroluminescent device has, between a pair of electrodes, at least one organic layer including a light-emitting layer, in which the organic layer contains a specific tetraphenylene compound |
| 02/01/2011 | US7879895 Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |